Information Library
Results for: Hear From the Experts - Demonstrating Value
To learn more about Quintiles’ services, you may broaden or narrow your search by selecting the topics at left.
- Sort by:
- Recently Added
- Title
-
The Power of Observation
January 26, 2012
As the name implies, in observational studies one 'observes.' The choice of therapy is determined by the patient and her physician rather than protocol, and, -
Making Observational Studies Count
January 26, 2012
There is substantial interest in using observational epidemiologic research in combination with randomized clinical trials (RCTs) and meta-analyses to support decisionmaking by regulators, payers, and -
Patient Registries for Understanding the Natural History of Diseases
January 26, 2012
Understanding the natural history of a disease - its characteristics. management. and outcomes with or without treatment - is critical for developing new therapies. identifying -
Commentary: The Real-world Convergence of Comparative Effectiveness Research and Risk-Benefit Assessment
November 10, 2011
Concerns about safety, value, and outcomes are driving demand for more robust evidence about biopharmaceuticals and other medical interventions. -
The Effect of Comparative Effectiveness Research on Drug Development Innovation
May 20, 2011
In healthcare the drug development process is in dire need of transformation, and Comparative Effectiveness Research (CER) is helping to fundamentally change drug development by forcing biopharmaceutical manufacturers to view drug innovation from a holistic, 360 degree perspective. -
New Healthcare Architecture to Maximize Vaccine Coverage Rates
April 19, 2011
Jason Baumgartner discusses the steps required to create a complete healthcare architecture the shift among biopharma toward preventive medicine. -
Podcast: Observational Research through Online Patient Communities
March 26, 2011
Elisa Cascade, Vice President of MediGuard, discusess how observational research can be conducted with the rich real-world outcomes data available through online patient communities. -
Podcast: Biopharma Needs Value Focused Commercial Model
September 30, 2010
Jim Featherstone, Vice President within the Consulting group at Quintiles, talks to Outsourcing-Pharma about some of the challenges of commercializing a new drug product -
Podcast: Clinical / Commercial Convergence
August 26, 2010
John Doyle explains the concept of clinical / commercial convergence. -
Podcast: Biopharma's Commercialization Challenges
April 19, 2010
Michael Ackermann, Ph.D., Vice President of Global Commercial Strategy and Alliance, Global Commercial Solutions at Quintiles, discusses the factors that are leading to a radical shift in how biopharmaceutical products are developed and commercialized.
